References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Iyeretal(1999)Effectsofpirfenidoneonprocollagengeneexpressionatthetranscriptionallevelinbleomycinhamstermodeloflungfibrosis.J.Pharmacol.Exp.Ther.289211PMID:10087006
KehrerandMargolin(1997)Pirfenidonediminishescyclophosphamide-inducedlungfibrosisinmice.Toxicol.Lett.90125PMID:9067480
Meietal(2005)Protectionofpirfenidoneagainstanearlyphaseofoleicacid-inducedacutelunginjuryinrats.J.Pharmacol.Exp.Ther.313379PMID:15608079
Okuetal(2002)Pirfenidonesuppressestumornecrosisfactor-α,enhancesinterleukin-10andprotectsmicefromendotoxicshock.Eur.J.Pharmacol.446167PMID:12098599
Keywords:Pirfenidone,supplier,Antifibrotic,agent,regulates,cytokine,levels,vivo,TNF-α,TNF-alpha,Interleukins,Tumor,Necrosis,Factor-α,Factor-alpha,Cytokines,Cytokine,NF-κB,NF-kappaB,Signaling,Signalling,esbriet,Cytokines,Cytokines,TocrisBioscience